Using a new biofeedback device to help women with stress urinary incontinence
Official title: Effectiveness and Cost-effectiveness of PelviSense, a Novel Biofeedback Device With Wearable Sensors for Stress Urinary Incontinence in Women: a Randomised Controlled Trial Alongside Economic Evaluation
Run by The Hong Kong Polytechnic University · NCT05627726 · Data updated 2026-11-12
This study tests whether a new biofeedback device can help women with stress urinary incontinence improve their pelvic floor muscle training and overall symptoms compared to doing it on their own.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 65 Years |
| Sex | Women only |
| Enrollment | 142 (estimated) |
| Sponsor | The Hong Kong Polytechnic University Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Hong Kong and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | October 26, 2025 |
| Study ends | October 26, 2026 |
| Registry record updated | March 17, 2025 |
| Trial ID | NCT05627726 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are non-pregnant women aged 35 to 65 with mild to moderate stress urinary incontinence.
✕Probably not a fit
Patients who may not benefit include those with severe pelvic organ prolapse, severe psychological issues, or those who are postpartum within the last six months.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of the PelviSense device in assisting pelvic floor muscle training (PFMT) for women suffering from stress urinary incontinence (SUI). It compares the outcomes of women using PelviSense with those performing PFMT alone, focusing on symptom severity and cost-effectiveness. The study employs a randomized controlled trial design and includes semi-structured focus groups to gather qualitative insights from participants about their experiences. A total of 142 women aged 35 to 65 with mild to moderate SUI will be enrolled to assess the device's impact on their lives and well-being.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive and effective treatment option for women suffering from stress urinary incontinence.
How similar studies have gone: While there have been studies on various adjunctive therapies for PFMT, the PelviSense device represents a novel, non-invasive approach that has not been extensively tested in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * non-pregnant women with stress urinary incontinence (SUI), * aged 35 to 65 years, * women who experience mild to moderate SUI, as indicated by a pad weight gain of 1-50 g during the 1-hour pad test with stress test, * women with a score ≥24 on the Mini-Mental State Examination. Exclusion Criteria: * women \<6 months postpartum, * women with severe pelvic organ prolapse, * women with complicated SUI due to pelvic region radiation, * women with a body mass index (BMI) ≥30, * women with severe psychological problems impairing study participation, * women with mixed urinary incontinence (MUI) or urge urinary incontinence (UUI)
Where it's running
-
The Hong Kong Polytechnic University
Hong Kong, Hong Kong Recruiting -
Kwong Wah Hospital
Kowloon, Hong Kong Recruiting
Study contacts
- Principal investigator: PRIYA KANNAN, PhD — The Hong Kong Polytechnic University
- Study coordinator: PRIYA KANNAN, PhD
- Email: priya.kannan@polyu.edu.hk
- Phone: 3400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if increasing running cadence helps stress urinary incontinence in parous runners
This study tests whether increasing running cadence by about 10% for eight weeks can reduce stress urinary incontinence symptoms in parous women who run regularly and own a Garmin watch.
-
Prophylactic antibiotics to reduce post-procedure UTIs after urethral bulking
We’re testing whether giving a preventive antibiotic at the time of urethral bulking can lower the chance of a urinary tract infection after the procedure for women with stress or mixed urinary incontinence.
-
Evaluating the impact of different mesh widths in surgery for urinary incontinence
This study is testing whether using a wider surgical mesh during surgery for urinary incontinence in women can lead to better results and fewer problems.
-
Evaluating postoperative activity restrictions after midurethral sling placement
This study is testing whether patients who have had a midurethral sling procedure for stress urinary incontinence do better with strict activity limits or no limits after surgery.
-
Comparing two procedures for treating stress urinary incontinence during vaginal prolapse repair
This study is testing whether a new type of surgery or an injection is better for helping women with stress urinary incontinence during vaginal prolapse repair.
-
Effectiveness and safety of shorter tapes for urinary incontinence
This study looks at whether shorter surgical tapes for treating urinary incontinence in women can improve their quality of life and have fewer complications compared to longer tapes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.